🔎 Trials Near Me

Utama › Penyakit Endokrin › California

Kajian klinikal Penyakit Endokrin di California

6 kajian untuk Penyakit Endokrin sedang mencari peserta di lokasi di California.

Teks kajian rasmi (Bahasa Inggeris)

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

  • Ascendis Pharma Investigational Site, Palo Alto
  • Ascendis Pharma Investigational Site, Sacramento
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07221851

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • San Fernando Valley Health Institute, Canoga Park
  • Headlands Research California, LLC, Escondido
  • ImmuniMet, LLC, Modesto
  • dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07595549

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

  • Kaiser Permanente Northern California, Pleasanton
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07776353

Study of BHV-1300 in Graves' Disease

  • Site-103, South Gate
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06980649

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • St Joseph Heritage Healthcare, Santa Rosa
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Limb Preservation Platform Inc, Fresno
  • Angel City Research, Los Angeles
  • Clemente Clinical Research, Los Angeles
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2025 · NCT06681428

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.